Effects of chemotherapy and tamoxifen on cervical and vaginal smears in bone marrow transplant recipients

Acta Cytologica

Volumn 43, Issue 6, 1999, Pages 1027-1033

  Liu, Katharine ^a   Marshall, Jay ^d   Shaw, Heather S ^b   Dodge, Richard K ^d   Layfield, Lester J ^c  

^a University Hospital Augusta   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^d NONE

Author keywords

Bone marrow transplantation; Cervical smears; Chemotherapy; Tamoxifen; Vaginal smears

Indexed keywords

CYCLOPHOSPHAMIDE; TAMOXIFEN; THIOTEPA;

ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; BREAST CARCINOMA; CANCER HORMONE THERAPY; CONTROLLED STUDY; DRUG SAFETY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OVARY CARCINOMA; PRIORITY JOURNAL; SQUAMOUS EPITHELIUM; UTERINE CERVIX CYTOLOGY; VAGINA SMEAR;

EID: 0032749938     PISSN: 00015547     EISSN: 19382650     Source Type: Journal    
DOI: 10.1159/000331349     Document Type: Article

References (29)

1. Athanassiadou PP, Krykou KA, Antoniades LG, Athanassiades PH: Cytological evaluation of the effect of Tamoxifen in premenopausal and post-menopausal women with primary breast cancer by analysis of the karyopyknotic indices of vaginal smears. Cytopathology 1992;3:203-208
2. Ayoubi JM, Monrozies X, Ayoubi F, Charasson T, Reme JM: Tamoxifene et frottis cervicovaginal. Rev Fr Gynecol Obstet 1994;89:216-220
3. Budel VM, Paridaens RJ, Spetschinsky A, Heuson JC, Gompel C: Effects of aminoglutethimide plus hydrocortisone on the genital tract of postmenopausal women with advanced breast cancer: A clinical and cytologic survey. Anticancer Res 1986;6:709-712
4. DeMay RM: The Art and Science of Cytopathology. Chicago, ASCP Press, 1996
5. Doss BJ, DeMay RM, Larson RA, Williams R, Montag AG: Chemotherapy induced epithelial atypia in the female lower genital tract (abstr). Mod Pathol 1995;89A
6. Eells TP, Alpern HD, Grzywacz C, MacMillan RW, Olson JE: The effect of tamoxifen on cervical squamous maturation in Papanicolaou stained cervical smears of post-menopausal women. Cytopathology 1990;1:263-268
7. Feingold ML, Koss LG: Effects of long-term administration of busulfan: Report of a patient with generalized nuclear abnormalities, carcinoma of vulva, and pulmonary fibrosis. Arch Intern Med 1969;124:66-71
8. Fotiou S, Tserkezoglou A, Hadjieleftheriou G, Apostolikas N, Karydas I, Stravolemos K: Tamoxifen associated uterine pathology in breast cancer patients with abnormal bleeding. Anticancer Res 1998;18:625-629
9. Gu M, Jacobsen J, Erroll M, Hoda SA: Pap smears of patients on tamoxifen (lett). Diagn Cytopathol 1997;16:96-97
10. Gupta S, Mukherjee K, Gupta YN, Kumar M: Sequential radiation changes in cytology of vaginal smears in carcinoma of cervix uteri during radiotherapy. Int J Gynaecol Obstet 1987;25:303-308
11. Gureli N, Denham SW, Root SW: Cytologic dysplasia related to busulfan (Myleran) therapy: Report of a case. Obstet Gynecol 1963;21:466-470
12. Hall TC, Dederick MM, Taft PD: Nonhormonal cancer chemotherapy and the vaginal smear. Cancer Chemother Rep 1967;51:231-234
13. Kluskens LF, Hong HY, Bibb LM: Effects of therapy on cytologic specimens. In Comprehensive Cytopathology. Second edition. Edited by M Bibbo. Philadelphia, WB Saunders, 1997, pp 865-885
14. Koss LG: Diagnostic Cytology and Its Histopathologic Bases. Fourth edition. Philadelphia, JB Lippincott, 1992
15. Koss LG, Melamed MR, Mayer K: The effect of busulfan on human epithelia. Am J Clin Pathol 1965;44:385-397
16. Kraus H, Schuhmann R, Ganal M, Geier G: Cytologic findings in vaginal smears from patients under treatment with cyclophosphamide. Acta Cytol 1977;21:726-730
17. Kurman RJ, Solomon D: The Bethesda System for Reporting Cervical/Vaginal Cytologic Diagnoses: Definitions, Criteria, and Explanatory Notes for Terminology and Specimen Adequacy. New York, Springer, 1994
18. Lahti E, Vuopala S, Kauppila A, Blanco G, Ruokonen A, Laatikainen T: Maturation of vaginal and endometrial epithelium in postmenopausal breast cancer patients receiving long-term tamoxifen. Gynecol Oncol 1994;55:410-414
19. McGonigle KF, Lantry SA, Odom-Maryon TL, Chai A, Vasilev SA, Simpson JF: Histopathologic effects of tamoxifen on the uterine epithelium of breast cancer patients: Analysis by menopausal status. Cancer Lett 1996;101:59-66
20. McLennan MT, McLennan CE: Significance of cervicovaginal cytology after radiation therapy for cervical carcinoma. Am J Obstet Gynecol 1975;121:96-100
21. Nelson BM, Andrews GA: Breast cancer and cytologic dysplasia in many organs after busulfan (Myleran). Am J Clin Pathol 1964;42;37-44
22. Nelson J, Makary AZ, Kough RH: Case report: Effect of anti-neoplastic chemotherapy on cervical cytology. Pa Med 1979;82:44-16
23. Nyberg G, Eriksson O, Westberg NG: Increased incidence of cervical atypia in women with systemic lupus erythematosus treated with chemotherapy. Arthritis Rheum 1981;24: 648-650
24. Patten SF, Reagan JW, Obenauf M, Ballard LA: Postirradiation dysplasia of uterine cervix and vagina: an analytical study of the cells. Cancer 1963;16:173-182
25. Schachter A, Kopmar A, Avram E, Gorodeski IG, Segal A: Hormonal and cytopathological changes in vaginal and cervical smears from women undergoing chemotherapy for extragenital malignant diseases. Acta Obstet Gynecol Scand 1983;62:621-624
26. Vooijs GP: Benign proliferative reactions, intraepithelial neoplasia, and invasive cancer of the uterine cervix. In Comprehensive Cytopathology. Second edition. Edited by M Bibbo. Philadelphia, WB Saunders, 1997, pp 161-230
27. Ward HN, Konikov N, Reinhard EH: Cytologic dysplasia occurring after busulfan (Myleran) therapy: A syndrome resembling adrenocortical insufficiency and atrophic bronchitis. Ann Intern Med 1965;63:654-660
28. Wentz WB, Reagan JW: Clinical significance of postirradiation dysplasia of the uterine cervix. Am J Obstet Gynecol 1970;106:812-817
29. Zinca V, Strimbeanu I: Morphological aspects in exfoliative vaginal cytology following anticancerous chemotherapy. Neoplasma 1963;10:397-404